Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints new SVP for Europe

Sanofi has announced the appointment of Peter Guenter as senior vice president, Europe, effective July 15, 2011

Sanofi has announced the appointment of Peter Guenter as senior vice president, Europe, effective July 15, 2011. Guenter is to report to the president of global operations, Hanspeter Speck, and will join the management committee.

During his time at Sanofi, Guenter has held various positions in France, Europe and global marketing. In 2000, Guenter was promoted to the role of general manager Belgium. Over the next few years he took responsibility for Eastern Europe, Northern Europe and Scandinavia as vice president. His most recent role is as general manager of commercial operations for Germany, the role he presently holds.

Guenter succeeds Belen Garijo, who leaves to take a leading role in another pharmaceutical company. Speck commented on Garijo's achievements during her time with the company:

"I would like to sincerely express my gratitude to Belen for her dedication to the company over the last 15 years. With her combination of experience, skill, passion and commitment, Belen was able to drive the transformation of Sanofi in Europe over the past several years. We wish her all the best for her new professional opportunity."

Speck also expressed his enthusiasm for Guenter's appointment:

"The depth of knowledge and experience Peter gained through his previous management roles in Germany and in Europe, as well as his general business acumen make him ideally suited to lead Sanofi's operations in Europe."

Prior to his involvement with Sanofi, Guenter gained a Masters in Physical Education and worked in sales at SmithKline from 1986 until he joined Sanofi in 1995.

28th June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics